Philips Respironics

What Philips Respironics does

Philips Respironics is the sleep and respiratory care subsidiary of Royal Philips N.V. (Koninklijke Philips N.V.), a Dutch diversified health technology conglomerate publicly traded on Euronext Amsterdam under ticker PHIA. The company develops, manufactures, and distributes medical devices for obstructive sleep apnea (OSA), chronic obstructive pulmonary disease (COPD), and broader respiratory care, including Continuous Positive Airway Pressure (CPAP) and Bi-level Positive Airway Pressure (BiPAP) machines, obstructive sleep apnea masks and accessories, portable oxygen concentrators (notably the SimplyGo Mini at approximately 5 pounds with FAA approval), cough assist devices, non-invasive ventilators (BiPAP V30 Auto, A30, A40), and smart exertion breath trainers. The core technology platform combines electromechanical respiratory hardware with emerging wireless, cloud, and AI-assisted remote monitoring capabilities on its connected BiPAP line.

The business model is primarily hardware sales to enterprise healthcare buyers (sleep clinics, hospitals, durable medical equipment suppliers, and home healthcare providers) complemented by direct-to-consumer access via the US Patient Portal for recall-affected device registration and replacement. Pricing is quote-based and not publicly disclosed, conducted through professional healthcare channels rather than consumer e-commerce. Customer segments are fragmented across sleep disorder patients, respiratory care patients (COPD, asthma), ventilation and critical care patients (neuromuscular disease, spinal cord injury), and the prescribing healthcare provider ecosystem serving them.

Since 2021, the company has operated under an FDA consent decree following a massive global recall of CPAP and BiPAP machines containing PE-PUR sound abatement foam that could release toxic particles and gases into users' airways, with over 500 death reports subsequently filed with the FDA. The recall has triggered lawsuits, congressional investigation, manufacturing halts, and a ~200-employee layoff at Pittsburgh-area facilities announced for late 2025 through mid-2026. The company continues to operate within Philips' broader portfolio alongside Sonicare (oral care), Norelco (grooming), Avent (mother and child care), and Philips Hue (lighting), but its near-term trajectory is shaped by recall remediation, replacement-device rollout, and renewed product launches in oxygen therapy and connected ventilation.

Name

Philips Respironics

Legal name

Koninklijke Philips N.V.

Website

https://usa.philips.com

Company type

Public

Founded year

1891

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Philips Respironics, the sleep and respiratory care subsidiary of Royal Philips, develops and manufactures CPAP/BiPAP machines, portable oxygen concentrators, sleep apnea masks, and ventilation devices, serving sleep apnea, COPD, and respiratory patients through sleep clinics, hospitals, DME suppliers, and home healthcare providers.

Ownership category

akta.pro rank

Product category

Sleep and Respiratory Care Medical Devices

NAICS

Electronic and Precision Equipment Repair and Maintenance (81121), Electronic and Precision Equipment Repair and Maintenance (811210)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Sleep Apnea Therapy Devices (CPAP/APAP/BiPAP/ASV) (HLAHAGAA)

akta.pro secondary industries

Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home) (HLAHAGAC), Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC) (HLAHAGAD), Noninvasive Ventilation Interfaces & Consumables (Masks, Tubing, Humidifiers, Filters) (HLAHAGAG), Home Respiratory & Sleep Therapy Providers (DME-Integrated) (HLAFAEAF), Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers) (HSABAKAD)

Keywords

• CPAP therapy devices
• BiPAP ventilators
• Portable oxygen concentrators
• Sleep apnea diagnostics
• Respiratory care equipment

Headquarters

HQ city

Philips

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. CPAP/BiPAP Device Sales: Primary revenue from Continuous Positive Airway Pressure (CPAP) and Bi-level Positive Airway Pressure (BiPAP) devices for sleep apnea therapy. Market projected to surpass US$7.2 billion by 2034.
2. Sleep Apnea Masks and Accessories: Replacement masks and accessories for sleep apnea therapy devices, serving both initial patients and the significant replacement demand created by the 2021 recall.
3. Oxygen Therapy Devices: Portable oxygen concentrators and oxygen therapy solutions for chronic respiratory conditions. Market projected to grow to USD 10.06 billion by 2033.
4. Breath Training Devices: Smart exertion breath trainers for respiratory health solutions across sports, fitness, and medical rehabilitation sectors.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels3 records

Core offering

Philips Respironics develops, manufactures, and distributes medical devices for the diagnosis and treatment of sleep and respiratory disorders. Core products include CPAP and BiPAP machines for obstructive sleep apnea therapy, portable oxygen concentrators such as the SimplyGo Mini for chronic respiratory conditions, home sleep apnea testing devices, respiratory masks, and cough assist and breath training devices for clinical and home use.

Product overview

Philips Respironics offers a portfolio of respiratory care and sleep therapy devices including portable oxygen concentrators, sleep apnea testing and treatment devices, BiPAP/CPAP ventilators, and breath training devices. The company's product ecosystem addresses respiratory health conditions such as COPD, asthma, and obstructive sleep apnea, serving both home healthcare and clinical settings.

Differentiator

Problem solved

Functional benefit

Brands

• Philips Sonicare: Electric toothbrushes and oral healthcare products including Sonicare electric toothbrushes, replacement brush heads, and power flossers
• Philips Norelco
• Philips Norelco OneBlade
• Philips Zoom
• Simply Go Mini
• Philips Avent

Products and services

• CPAP and BiPAP Therapy Devices CPAP and BiPAP devices for treating obstructive sleep apnea (OSA), incorporating AI, wireless connectivity, and cloud-based remote patient monitoring in newer models. Used by sleep clinics and home healthcare providers to deliver therapy to sleep apnea patients.
• Home Sleep Apnea Testing (HSAT) Devices Home-based diagnostic devices for detecting obstructive sleep apnea. Contributing to the global home sleep apnea testing devices market estimated at US$1.1 billion in 2025.
• Obstructive Sleep Apnea Masks Masks for obstructive sleep apnea therapy, sold as part of the sleep apnea mask market for homecare, hospitals, and sleep clinic segments, including initial patient masks and replacement masks driven by recall demand.
• SimplyGo Mini Portable Oxygen Concentrator Portable oxygen concentrator for active oxygen therapy users, weighing approximately 5 pounds with standard battery, five adjustable pulse-dose settings, oxygen output of 220-1000 ml/min at 87%-96% purity, up to 4.5 hours (standard battery) or 9 hours (extended battery), FAA-approved for air travel.
• Cough Assist Devices Mechanical devices designed to assist coughing in patients with neuromuscular respiratory conditions, part of a market expected to reach $3.12 billion by 2030.
• Breath Training Devices Devices for breath training applications across health, sports, fitness, and medical rehabilitation sectors.
• Smart Exertion Breath Trainer Smart breathing trainer device used across medical, fitness, and wellness applications, in a market reaching USD 1.12 billion in 2024.
• BiPAP V30 Auto / A30 / A40 Ventilators Non-invasive ventilation devices used in hospital and homecare settings, with FDA alert issued regarding Ventilator Inoperative alarm failure.

Quantifiable outcome

• Home sleep apnea testing market growth driven by Philips Respironics consent decree creating replacement demand
• +1 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered minor.

• ResMed Inc.minorOthersPhilips Respironics and ResMed Inc. are frequently co-profiled in market research reports as the two leading players in the global home sleep apnea testing devices market, alongside Itamar Medical. They compete across sleep apnea therapy, CPAP/BiPAP devices, and respiratory care markets.
• Fisher & Paykel HealthcareminorOthersPhilips Respironics and Fisher & Paykel Healthcare are co-profiled in market research reports covering the obstructive sleep apnea mask market and respiratory care devices market. Both companies compete in sleep apnea therapy and respiratory care device segments.
• Itamar MedicalminorOthersPhilips Respironics and Itamar Medical are mentioned together in market analysis reports covering the home sleep apnea testing devices market as key industry players alongside ResMed Inc.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• ResMed Inc. ResMed is Philips Respironics' largest direct competitor in CPAP/BiPAP sleep apnea therapy devices, masks, and connected health. Post-2021 recall, ResMed captured significant share in the same sleep clinic and home DME channels.
• Fisher & Paykel Healthcare: Fisher & Paykel Healthcare directly competes in CPAP/BiPAP devices, OSA masks, and respiratory humidification, co-profiled with Philips Respironics in sleep apnea mask market research. Strong presence in hospitals and home respiratory care.
• Invacare Corporation: Invacare is a long-standing respiratory and DME manufacturer producing oxygen concentrators and respiratory care equipment directly competing with Philips Respironics in home respiratory therapy for COPD and chronic conditions.

Emerging players

• Itamar Medical: Itamar Medical (now part of ZOLL/Asahi Kasei) is co-profiled with Philips Respironics in the home sleep apnea testing (HSAT) market, offering WatchPAT diagnostic devices that compete with Philips' home sleep testing portfolio.
• React Health (formerly 3B Medical): React Health manufactures CPAP devices, masks, and sleep apnea therapy accessories, competing with Philips Respironics in the sleep & respiratory DME channel with growing US distribution.
• Apex Medical Corp. Apex Medical manufactures CPAP/BiPAP devices, oxygen concentrators, and respiratory care products, competing with Philips Respironics particularly in homecare and emerging market respiratory channels.
• BMC Medical Co., Ltd. BMC Medical is a Chinese manufacturer of CPAP/BiPAP devices and sleep apnea masks competing with Philips Respironics globally, particularly in cost-sensitive and emerging market respiratory segments.

Broad incumbents

• Drive DeVilbiss Healthcare: Drive DeVilbiss Healthcare manufactures and distributes CPAP, BiPAP, oxygen concentrators, and related DME competing broadly with Philips Respironics across home respiratory care and DME provider channels.

Regional players

• Chart Industries (incl. Sechrist Industries): Chart Industries (via Sechrist and CAIRE) manufactures medical oxygen concentrators and ventilators competing with Philips Respironics' hospital and portable oxygen therapy lines, with strength in US hospital and clinical settings.
• Lowenstein Medical Technology: Lowenstein Medical is a German manufacturer of CPAP/BiPAP devices, ventilators, and sleep diagnostics directly competing with Philips Respironics across European sleep medicine and hospital respiratory markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/philips
• Instagraminstagram.com/philipssonicare
• Xx.com/philipsna

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Philips Respironics